An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, according to a new study.
Month: October 2022
Northwestern Medicine investigators have discovered that a particular enzyme is essential for regulating cancer cell survival and metastasis under cellular stress, according to a recent study.
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
Northwestern Medicine investigators have uncovered novel regulatory mechanisms that promote bacterial survival, according to findings published in PNAS.
Therapeutically targeting ion channels in nociceptor neurons may be a promising strategy for managing osteoarthritis pain, according to a Northwestern Medicine study.
A new study shows physicians may be choosing to deny care to people with disabilities, and some use discretionary excuses to strategically discharge them from their practice.
Faculty, staff and students shared presentations, workshops and discussions on the future of medical education at Feinberg’s 12th annual Medical Education Day, held September 30.